Articles with category: Article
Step into the light
Cover story summary: Personal stories of drug use, highlighting consumer perspectives
Q&A: Lizzie Marvelly
We introduce the Drug Foundation’s newest board member Lizzie Marvelly, who brings rich experience from the worlds of music, media and social change.
The right message: Engaging teens and young people
Update on how 'peer crowds' research is being used to inform a range of youth-focused projects
Cheese, chocolate, watches - and heroin-assisted treatment
Switzerland’s national drug policy, introduced in the 1990s, comprises four pillars: prevention, therapy, harm reduction and prohibition. The Swiss public voted the approach into law in 2008.
Cannabis causes 32 deaths each year in New Zealand... Really?
All drug use has a risk of harm, which can include death. This Viewpoints argues either side of the question: Does cannabis cause 32 deaths each year in New Zealand?
Drivers of change
What hope is there that this is the direction law makers will take in our new Parliament? Emma Espiner examines the prospects.
Revenge of the Hastings Incubus
The long, mostly hidden and quietly swoony story of the Kiwi relationship with heroin (diamorphine): Redmer Yska traces New Zealand’s history of heroin.
On addiction and the politics of compassion
Mental health is notably on the agenda this election (and hopefully post-election). Given our suicide rate now sits at a heart-breaking 606 people in the last year, this focus is long overdue.
Public mood swing: Have Asia’s brutal drug wars hit a nerve?
Recent teen deaths in the Philippines have sparked massive public outrage. Could this be a turning point for President Duterte’s bloody War on Drugs?
Enlightenment at the end of the maze
Our Through the Maze symposium in July was a starting point for change.
Tūhoetanga
Ngāi Tūhoe and the Drug Foundation invited experts and community leaders to come together in Rūatoke to declare war on drug dependence.
Without warning
New Zealand has little in the way of a drug early warning system for emerging substances and usage trends. Rob Zorn summarises the issues and looks at a couple of existing systems we could emulate.